Generic Name and Formulations:
Sulfacetamide sodium 10%; oph. soln; contains benzalkonium chloride.
- Tau Associated With Loss of Anterior Temporal White Matter Integrity
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Hypertension: Beta-Blocker Pharmacokinetics
- Hypertension Treatments: ACE Inhibitors
- Combination Hypertension Treatments
Indications for BLEPH-10:
Susceptible infections of conjunctiva and cornea. Adjunct in trachoma.
Adults and Children:
<2months: not recommended. ≥2months: Conjunctivitis: 1–2 drops every 2–3 hrs during the day (less often at night). Trachoma: 2 drops every 2 hrs w. systemic therapy.
Purulent exudates may inactivate drug. Discontinue if hypersensitivity or rash occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Incompatible with silver-containing preparations. May be antagonized by PABA.
Local irritation, stinging, burning, superinfection, sensitization.
Neurology Advisor Articles
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications